Welcome to our dedicated page for Kindly Md SEC filings (Ticker: NAKA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Kindly Md's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Kindly Md's regulatory disclosures and financial reporting.
Jefferies Financial Group Inc. (JEF) is marketing a new structured debt security: Senior Autocallable Contingent Coupon Barrier Notes due 16-Jul-2030. The notes are senior unsecured obligations issued under the Series A Global Medium-Term Notes programme and are subject to JEF鈥檚 credit risk.
Key commercial terms
- Issue price / Face: $1,000 per note.
- Estimated value on pricing date: 鈮� $980.20 (鈮� 1.98 % below issue price, reflecting distribution & hedging costs).
- Maturity: 16-Jul-2030 (5-year tenor).
- Contingent coupon: $12.75 per month (鈮� 15.3 % p.a.) paid only if the worst-performing underlying on each monthly observation date is 鈮� 75 % of its initial level.
- Auto-call feature: Beginning Jan 2026, the notes are automatically redeemed at par plus the coupon if the worst-performing underlying is 鈮� 100 % of its initial level on any monthly call observation date.
- Downside exposure: At maturity investors receive 100 % of principal only if the worst-performing underlying is 鈮� 60 % of its initial level. Below 60 %, repayment is reduced 1-for-1 with the underlying鈥檚 decline, exposing holders to up to 100 % loss of principal.
- Underlying basket (worst-of methodology): VanEck Semiconductor ETF (SMH), Russell 2000 Index (RTY) and Nasdaq-100 Index (NDX).
- Coupon barrier: 75 % of initial level; Threshold value: 60 % of initial level; Observation schedule: monthly (dates provided on PS-3 鈥� PS-4).
- Distribution fees: Dealer concessions up to 0.60 % of face; Jefferies LLC acts as agent and faces FINRA Rule 5121 conflict-of-interest restrictions.
Risk highlights
- Credit risk: Payments depend on JEF鈥檚 ability to meet obligations; the notes rank pari passu with other senior unsecured debt.
- Market risk: Principal is at risk if any underlying falls > 40 % from its initial level at maturity; coupons are not assured.
- Liquidity: No exchange listing; secondary market, if any, will be made on a best-efforts basis by Jefferies LLC and may reflect a bid-ask spread and JEF鈥檚 secondary market funding rate.
- Valuation: Initial estimated value is below issue price; early account statements will include a temporary upward adjustment that amortises to zero during the 鈥淭emporary Adjustment Period鈥�.
Recent issuer performance (fiscal Q2 2025, ended 31-May-2025)
- Investment Banking net revenue: $766 m
- Capital Markets net revenue: $704 m
- Asset Management net revenue: $155 m
- Income before tax: $135 m; Net income: $88 m (effective tax rate 32.3 %)
Six-month cumulative figures show $3.22 b total net revenue and $216 m net income, indicating continued profitability ahead of this debt issuance.
Investor takeaway: The notes offer a high contingent coupon and potential early redemption, but they cap upside, expose principal to significant downside linked to the worst-performing of three equity benchmarks and rely on JEF鈥檚 credit quality. They are suited only for investors comfortable with both issuer credit exposure and structured-product market risk.
Kindly MD, a Utah-based healthcare company focused on hospitals and physicians, has filed Form D for an exempt securities offering under Rule 506(b). The company has successfully completed a $711.7 million offering, with the entire amount already sold to 156 investors.
Key details of the offering include:
- Sales commissions of $20.6 million and finder's fees of $293,400
- Cohen & Company Capital Markets and Anthem Securities LLC serving as brokers, receiving equity fees of 2% and 0.5% respectively of post-closing common stock
- Offering includes equity, debt, and options/warrants
- Connected to a business combination transaction (merger/acquisition)
The company's leadership includes Timothy Pickett as CEO and Director, with other executives Jared Barrera and Adam Cox. The board includes Amy Powell, Christian Robinson, and Gary Seelhorst. The offering was marketed across multiple states including California, New York, Texas, and international markets.
KindlyMD (NASDAQ:NAKA) filed an 8-K announcing the appointment of Andrew Creighton as Chief Commercial Officer of Nakamoto Holdings. The filing indicates this is a Regulation FD disclosure, with the information being furnished rather than filed under Section 18 of the Securities Exchange Act. The company, which is classified as an emerging growth company, made this announcement via press release on June 25, 2025.
Kindly MD has announced a significant merger with Nakamoto Holdings through a complex transaction involving multiple financing components. Key details include:
- Merger agreement where Nakamoto will become a wholly-owned subsidiary of KindlyMD, with Nakamoto shareholders receiving 22.3 million shares at $1.12 per share
- PIPE financing of $511.7 million through subscription agreements at $1.12 per share
- Additional PIPE financing of $51.5 million at $5.00 per share
- Secured convertible debenture of $200 million with Yorkville Advisors
The transaction was approved by written consent of majority stockholders (50.76% voting power) on May 18, 2025, and additional approvals (50.14%) on June 19, 2025. Key governance changes include increasing authorized shares to 10 billion, implementing a classified board structure, and establishing exclusive forum provisions in Utah courts. The company will also adopt a new 2025 Equity Incentive Plan and issue up to 600 million shares under a Marketing Agreement with BTC.
Kindly MD has announced a significant private placement (PIPE Financing) of up to 10,300,000 shares of common stock at $5.00 per share, targeting an aggregate amount of $51.5 million. This financing is connected to a previously announced merger with Nakamoto Holdings.
Key details of the transaction include:
- The PIPE Financing will close concurrently with the merger completion
- Proceeds will be used to purchase Bitcoin and for working capital purposes
- Company will file registration statement within 30 days post-closing
- Majority shareholders approved the subscription agreements on June 19, 2025
The company's stock (NAKA) last traded at $13.94 per share, with tradeable warrants (NAKAW) at $8.43. The filing also covers 2,059,811 shares issuable upon exercise of previously issued warrants and 82,310 shares of common stock for resale by selling stockholders.
Kindly MD has announced a significant private placement (PIPE Financing) worth $51.5 million, approved by its board on June 19, 2025. The company will issue up to 10,300,000 shares of common stock at $5.00 per share to certain investors.
Key details of the PIPE Financing:
- Proceeds will be used to purchase Bitcoin and for working capital purposes
- Closing is contingent upon completion of previously announced merger with Nakamoto Holdings
- Company must file registration statement within 30 days post-closing
- Registration must be effective within 60-90 days of filing
Additionally, majority shareholders approved the subscription agreements and the issuance of over 20% of company's common stock to comply with Nasdaq listing rules. The securities will be issued under Section 4(a)(2) of the Securities Act exemption. The merger and PIPE financing must close by November 14, 2025, or the agreements may be terminated.
FAQ
What is the current stock price of Kindly Md (NAKA)?
What is the market cap of Kindly Md (NAKA)?
